Obesity stocks slump on Novo's underwhelming 2026 sales forecast [Yahoo! Finance Canada]
Structure Therapeutics Inc. - American Depositary Shares (GPCR)
Company Research
Source: Yahoo! Finance Canada
Eli ?Lilly was down about 4%, Structure Therapeutics fell 6.2%, while Altimmune dropped 4.2%. Viking Therapeutics declined more than 3% and Amgen slipped nearly 1% ?in afternoon trading. The ?Danish drugmaker said it expects sales to drop between 5% and 13% ?this year, compared with analysts' average expectation of a 2% decline. Its U.S.-listed shares fell 13.8% to $50.83. Wegovy-maker ?Novo also reported a 14% fall in ?fourth-quarter operating profit to 31.7 billion Danish crowns, slightly above the estimate of 31.2 billion crowns. The selloff comes as Wall Street is reassessing long-held expectations that the obesity drug market could ?hit $150 billion early next decade, ?as U.S. prices for GLP-1 ?treatments from Novo and Lilly fall sharply and competition intensifies in the cash-pay ?consumer market. Analysts ?have pushed out peak sales timelines and trimmed forecasts, with some now seeing the ?market closer to $80 billion to $105 billion by 2030. ($1 = 6.3201 ?Danish cr
Show less
Read more
Impact Snapshot
Event Time:
GPCR
Last Price
Price Change
Price Change%
Volume Shares
Max Up
Max Down
%
Volume Ratio
Performance Comparison
Updated
|
Event Day
Stock performance from the time of news release until the following 4pm ET market close
|
Last price at news event
|
Since Event
Multi-day stock performance from the time of the news release
|
|---|---|---|
|
EVENT DAY
Stock performance from the time of news release until the following 4pm ET market close
|
LAST
PRICE AT NEWS EVENT |
SINCE EVENT
Multi-day stock performance from the time of the news release
|
| Last Price | ||
| VWAP | ||
|
High:
|
Max Up |
High:
|
|
Low:
|
Max Down |
Low:
|
|
%
|
Post news range |
%
|
|
|
Price change |
|
|
|
Price Change Percentage |
|
|
|
S&P 500 (SPX) |
|
|
%
|
Volume ratio |
%
|
| Volume | ||
| Ticks | ||
|
|
Avg transaction size |
|
Don't Miss Out On The Next BIG Stock Move
Event day
Event Day Chart will not be displayed beyond 90-day period of the event
Performance since event
Time And Velocity Analysis
Be the first to know
Opt in for alerts from News Quantifed
Sign Up Today
Opt-in for
GPCR alerts
Learn More With NQ
Reading the Impact Report
Help Me Understand This Data
Help Me Understand This Data
How NQ Works
What is news-based trading?
And why is it so successful?
And why is it so successful?
Movers & Shakers
The biggest gainers and losers and WHY it moved
GPCR alerts
High impacting Structure Therapeutics Inc. - American Depositary Shares news events
Weekly update
A roundup of the hottest topics
GPCR
News
- Key deals this week: Apple, McEwen Mining, IonQ, Leidos, and more [Seeking Alpha]Seeking Alpha
- Structure Therapeutics (NASDAQ:GPCR) was downgraded by analysts at <a style="font-weight:bold" href="https://www.wallstreetzen.com/newsletters/zen-ratings?ticker=GPCR&utm_campaign=getratings&utm_medium=online&utm_source=MarketBeat">Wall MarketBeat
- Structure Therapeutics (NASDAQ:GPCR) had its "sell (d-)" rating reaffirmed by analysts at <a style="font-weight:bold" href="https://weissratings.com/">Weiss Ratings</a>.MarketBeat
- Structure Therapeutics (NASDAQ:GPCR) was upgraded by analysts at The Goldman Sachs Group, Inc. to a "strong-buy" rating.MarketBeat
- Structure Therapeutics (NASDAQ:GPCR) had its price target raised by analysts at JPMorgan Chase & Co. from $65.00 to $105.00. They now have an "overweight" rating on the stock.MarketBeat
GPCR
Sec Filings
- 1/20/26 - Form 4
- 1/5/26 - Form 8-K
- 12/10/25 - Form 8-K
- GPCR's page on the SEC website